LAUPHEIM, Germany--(BUSINESS WIRE)--Rentschler Biopharma SE, a leading contract development and manufacturing organization (CDMO) for biopharmaceuticals, today appointed Dr. Ralf Otto (46) as Chief ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results